JPMorgan Chase & Co’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-70,286
| Closed | -$3.21M | – | 4883 |
|
|
2017
Q4 | $3.21M | Sell |
70,286
-14,888
| -17% | -$681K | ﹤0.01% | 2505 |
|
|
2017
Q3 | $3.79M | Sell |
85,174
-27,950
| -25% | -$1.24M | ﹤0.01% | 2328 |
|
|
2017
Q2 | $3.38M | Buy |
113,124
+50,378
| +80% | +$1.51M | ﹤0.01% | 2347 |
|
|
2017
Q1 | $1.39M | Buy |
62,746
+60,001
| +2,186% | +$1.33M | ﹤0.01% | 2766 |
|
|
2016
Q4 | $51K | Sell |
2,745
-2,447
| -47% | -$45.5K | ﹤0.01% | 4018 |
|
|
2016
Q3 | $156K | Buy |
5,192
+418
| +9% | +$12.6K | ﹤0.01% | 3329 |
|
|
2016
Q2 | $184K | Sell |
4,774
-670
| -12% | -$25.8K | ﹤0.01% | 3256 |
|
|
2016
Q1 | $207K | Sell |
5,444
-47,086
| -90% | -$1.79M | ﹤0.01% | 3146 |
|
|
2015
Q4 | $2.31M | Sell |
52,530
-100,865
| -66% | -$4.44M | ﹤0.01% | 2311 |
|
|
2015
Q3 | $6.24M | Sell |
153,395
-301,651
| -66% | -$12.3M | ﹤0.01% | 1844 |
|
|
2015
Q2 | $24.3M | Buy |
455,046
+396,163
| +673% | +$21.1M | 0.01% | 1162 |
|
|
2015
Q1 | $3.57M | Buy |
58,883
+14,921
| +34% | +$905K | ﹤0.01% | 2276 |
|
|
2014
Q4 | $2.3M | Buy |
+43,962
| New | +$2.3M | ﹤0.01% | 2434 |
|